Morgan Stanley »

Design Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 478k 4.03
2023-09-30 $850k 360k 2.36
2023-06-30 $1.2M 191k 6.30
2022-12-31 $425k 41k 10.26
2022-06-30 $793k 39k 20.41
2022-03-31 $205k 13k 16.02
2021-06-30 $12k 647 18.92